MACULAR DEGENERATION
Clinical trials for MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drops aim to control wet macular degeneration
Disease control CompletedThis study tested three different doses of SYL1801 eye drops in 99 people with wet age-related macular degeneration (AMD). The goal was to see if the drops are safe and help maintain or improve vision. Participants received the eye drops and were monitored for changes in eyesight…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Sylentis, S.A. • Aim: Disease control
Last updated May 17, 2026 03:59 UTC
-
New drug shows promise in slowing blindness from dry AMD
Disease control CompletedThis study tested an eye injection called Zimura (avacincaptad pegol) in 448 people with geographic atrophy, a form of advanced dry age-related macular degeneration that causes permanent vision loss. The goal was to see if the drug could slow the growth of damaged areas in the re…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: IVERIC bio, Inc. • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New combo may cut painful eye injections for vision loss
Disease control CompletedThis study tested whether adding a light-based therapy (photodynamic therapy) to a standard drug injection (ranibizumab) could reduce the number of injections needed for wet age-related macular degeneration. 60 participants aged 50 and older with active disease were enrolled. The…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Texas Retina Associates • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Eye training shows promise for vision loss in macular degeneration
Knowledge-focused CompletedThis study tested new methods to measure and train eye movements in 21 people with macular degeneration and severe vision loss. Participants practiced using a different part of their retina to see, and researchers tracked changes in vision and eye movement over 14 weeks. The goal…
Matched conditions: MACULAR DEGENERATION
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC